These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18300867)

  • 1. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats.
    Krikov M; Thone-Reineke C; Müller S; Villringer A; Unger T
    J Hypertens; 2008 Mar; 26(3):544-52. PubMed ID: 18300867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
    Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
    J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
    Fu H; Hosomi N; Pelisch N; Nakano D; Liu G; Ueno M; Miki T; Masugata H; Sueda Y; Itano T; Matsumoto M; Nishiyama A; Kohno M
    J Hypertens; 2011 Nov; 29(11):2210-9. PubMed ID: 21934531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
    Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
    Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection.
    Fagan SC; Kozak A; Hill WD; Pollock DM; Xu L; Johnson MH; Ergul A; Hess DC
    J Hypertens; 2006 Mar; 24(3):535-9. PubMed ID: 16467657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.
    Hamai M; Iwai M; Ide A; Tomochika H; Tomono Y; Mogi M; Horiuchi M
    Neuropharmacology; 2006 Sep; 51(4):822-8. PubMed ID: 16824557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection.
    Elewa HF; Kozak A; Johnson MH; Ergul A; Fagan SC
    J Hypertens; 2007 Apr; 25(4):855-9. PubMed ID: 17351379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain.
    Schmerbach K; Schefe JH; Krikov M; Müller S; Villringer A; Kintscher U; Unger T; Thoene-Reineke C
    Brain Res; 2008 May; 1208():225-33. PubMed ID: 18378216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.
    Omura-Matsuoka E; Yagita Y; Sasaki T; Terasaki Y; Oyama N; Sugiyama Y; Okazaki S; Sakoda S; Kitagawa K
    Hypertens Res; 2009 Jul; 32(7):548-53. PubMed ID: 19424281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of a non-antihypertensive dose of ramipril on the plasma and tissue renin-angiotensin system in 27 TGR (mRen2) rats].
    Grima M; Anjuère J; Ingert C; Coquard C; Steger J; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):805-12. PubMed ID: 11575208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.
    Engelhorn T; Goerike S; Doerfler A; Okorn C; Forsting M; Heusch G; Schulz R
    J Cereb Blood Flow Metab; 2004 Apr; 24(4):467-74. PubMed ID: 15087716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.
    Engelhorn T; Doerfler A; Heusch G; Schulz R
    Neurosci Lett; 2006 Oct; 406(1-2):92-6. PubMed ID: 16901636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
    Raasch W; Jöhren O; Schwartz S; Gieselberg A; Dominiak P
    J Hypertens; 2004 Mar; 22(3):611-8. PubMed ID: 15076168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models.
    Thoene-Reineke C; Rumschüssel K; Schmerbach K; Krikov M; Wengenmayer C; Godes M; Mueller S; Villringer A; Steckelings U; Namsolleck P; Unger T
    PLoS One; 2011; 6(8):e23646. PubMed ID: 21901125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study.
    Kozak W; Kozak A; Johnson MH; Elewa HF; Fagan SC
    J Pharmacol Exp Ther; 2008 Sep; 326(3):773-82. PubMed ID: 18559971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of candesartan on the renin system in conscious rats.
    Wagner C; Kurtz A
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S169-71. PubMed ID: 9892158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candesartan-induced gene expression in five organs of stroke-prone spontaneously hypertensive rats.
    Kato N; Liang YQ; Ochiai Y; Birukawa N; Serizawa M; Jesmin S
    Hypertens Res; 2008 Oct; 31(10):1963-75. PubMed ID: 19015604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.